Planet 13 Holdings (PLNH) Non Operating Income (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Non Operating Income came in at $1.8 million in Q1 2026, down 63.23% year-on-year from $4.8 million in Q1 2025, and down 57.5% on a QoQ basis from $4.2 million in Q4 2025.
Planet 13 Holdings (PLNH) Non Operating Income (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Non Operating Income data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Non Operating Income fell 63.23% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 13.13% decrease from a year earlier, with the FY2025 full-year figure at $7.0 million, up 7835.96% from the prior year.
- Non Operating Income for Q1 2026 stood at $1.8 million, down from $4.2 million in the prior quarter.
- Over the last five years, Non Operating Income for PLNH reached as high as $4.8 million in Q1 2025 and fell as low as -$2.4 million in Q4 2022.
- Historically, Non Operating Income has averaged $333550.9 across 5 years, with a median of $109898.0 in 2023.
- Across the five-year window, Non Operating Income tumbled 726.22% in 2022 and surged 3449.35% in 2025, its largest moves.
- Year by year, Non Operating Income stood at -$2.4 million in 2022, then jumped by 52.97% to -$1.1 million in 2023, then jumped by 86.57% to -$149870.0 in 2024, then soared by 2870.51% to $4.2 million in 2025, then sank by 57.5% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $1.8 million in Q1 2026, $4.2 million in Q4 2025, and -$1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.76 Mn |
| Dec 31, 2025 | 4.15 Mn |
| Sep 30, 2025 | -1.89 Mn |
| Jun 30, 2025 | -51,810.00 |
| Mar 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | -149,870.00 |
| Sep 30, 2024 | 403,914.00 |
| Jun 30, 2024 | -479,844.00 |
| Mar 31, 2024 | 135,214.00 |
| Dec 31, 2023 | -1.12 Mn |
| Sep 30, 2023 | 109,898.00 |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | -1.72 Mn |
| Dec 31, 2022 | -2.37 Mn |
| Sep 30, 2022 | 291,613.00 |
| Jun 30, 2022 | -2.36 Mn |
| Mar 31, 2022 | 2.41 Mn |
| Dec 31, 2021 | -287,136.00 |
| Sep 30, 2021 | 6.75 Mn |
| Jun 30, 2021 | -2.05 Mn |